ARTICLE | Clinical News

Siga submits NDA for smallpox candidate

December 15, 2017 7:42 PM UTC

Siga Technologies Inc. (Pink:SIGA) submitted an NDA to FDA for oral TPOXX tecovirimat (oral ST-246) to treat smallpox infection. The company is seeking Priority Review of the small molecule antiviral...

BCIQ Company Profiles

Siga Technologies Inc.